French health technology company Withings has made a significant impact at CES 2025 with the announcement of two new products that further solidify its position in the consumer health tech market. The company, known for making clinical-grade health technologies accessible to consumers, has unveiled BPM Vision, a travel-sized home blood pressure monitor, and Cardio Check, a heart monitoring service.

BPM Vision is a notable addition to Withings' product lineup, offering users a convenient and accurate way to monitor their blood pressure at home. The $130 device is designed to be portable and easy to use, with interchangeable arm cuffs and a large screen that guides users through the measurement process. The system measures both systolic and diastolic blood pressure, enabling users to detect and control conditions like hypertension. Withings claims that the system delivers "clinical accuracy," making it a valuable tool for individuals who need to monitor their blood pressure regularly.

One of the standout features of BPM Vision is its ability to support up to eight user profiles, making it an ideal solution for families or individuals who need to track multiple users' blood pressure readings. The device is Wi-Fi enabled and has a built-in battery that lasts for over a year, ensuring seamless connectivity and minimal maintenance. The system is set to launch in the US in April, pending FDA approval.

In addition to BPM Vision, Withings has also introduced Cardio Check, a heart monitoring service designed to offer round-the-clock monitoring and early detection of heart problems such as atrial fibrillation (AFib). The service is available through the Withings+ subscription, which costs $10 per month, and is compatible with a range of Withings devices, including the ScanWatch, ScanWatch 2, ScanWatch Nova, ScanWatch Nova Brilliant, Body Scan scale, BPM Core, and the BeamO.

Subscribers to the Withings+ service will have access to up to four cardio checkups per year, providing them with valuable insights into their heart health. The service also offers access to board-certified cardiologists, further enhancing its value proposition. Cardio Check is set to launch on Tuesday, marking a significant expansion of Withings' health tech offerings.

The launch of BPM Vision and Cardio Check underscores Withings' commitment to making clinical-grade health technologies accessible to consumers. By providing users with accurate and convenient health monitoring solutions, Withings is empowering individuals to take control of their health and wellbeing. As the health tech market continues to evolve, Withings is well-positioned to remain at the forefront of innovation, driving growth and adoption in the consumer health tech space.

The implications of Withings' latest announcements are far-reaching, with potential benefits for individuals, healthcare providers, and the broader healthcare industry. As consumers increasingly turn to digital health technologies to manage their health, companies like Withings are playing a critical role in shaping the future of healthcare. With its latest products, Withings is further solidifying its position as a leader in the health tech space, and its commitment to innovation and accessibility is likely to have a lasting impact on the industry.